Company intelligence / Profile preview

Bio Fund Management

Helsinki, Finland

Ownership: Private
Development stage: Other

Overview

Bio Fund Management was a prominent venture capital firm based in Helsinki, Finland, specializing in the life sciences and healthcare sectors. Founded in 1997, the firm was a leading Nordic investor in biotechnology, pharmaceuticals, medical devices, and diagnostics, managing multiple funds with a total asset value of approximately €200 million. Its investment portfolio included several high-profile companies such as FibroGen, BioTie Therapies, Santaris Pharma, and Egalet. The firm was acquired by the Danish financial group Capinordic A/S in 2008, and its operations were subsequently integrated or wound down following the acquirer's financial difficulties.

Industry: Investors

Partnerships

Sitra (Finnish National Fund for Research and Development)

Beyond the preview

Go deeper on Bio Fund Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio Fund Management.

Explore the full profile